Rb localization and phosphorylation kinetics correlate with the cellular phenotype of cultured breast adenocarcinoma cells

In Vitro Cellular and Developmental Biology - Animal

Volumn 38, Issue 4, 2002, Pages 235-241

  Botos, Jeannine ^a   Barhoumi, Rola ^a   Burghardt, Robert ^a   Kochevar, Deborah T ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Breast neoplasms; Cell cycle proteins; Nuclear proteins; Phosphoproteins; Retinoblastoma protein

Indexed keywords

RETINOBLASTOMA PROTEIN;

ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL TYPE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; METASTASIS POTENTIAL; PHENOTYPE; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

ADENOCARCINOMA; BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL DIVISION; FEMALE; HUMANS; KINETICS; NEOPLASM METASTASIS; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0036550023     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1290/1071-2690(2002)038<0235:RLAPKC>2.0.CO;2     Document Type: Article

References (68)

1. Differential subcellular localization of protein phosphatase-1 α, γ1, and δ isoforms during both interphase and mitosis in mammalian cells
2. Cellular localization and T antigen binding of the retinoblastoma protein
3. Constitutively active protein phosphatase-1 alpha causes Rb-dependent G1 arrest in human cancer cells
4. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene
5. The retinoblastoma gene in breast cancer: Allele loss is not correlated with loss of gene protein expression
6. Rb function is a better indicator of cellular phenotype in cultured breast adenocarcinoma cells than Rb expression
7. Assay for nanogram quantities of DNA in cellular homogenates
8. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle
9. Breast tumor cell lines from pleural effusions
10. RB growth control evasion in lung cancer
11. Applications of fluorochromes to pollen biology, mithamycin and 4′6-diamidino-2-phenylindole (DAP1) as vital stains and for quantitation of nuclear DNA
12. A novel mutation in the promoter region in a family with a mild form of retinoblastoma indicates the location of a new regulatory domain for the RB1 gene
13. Retinoblastoma and p16 proteins in mammary carcinoma: Their relationship to cyclin D1 and histopathological parameters
14. Nuclear membrane dynamics and reassembly in living cells: Targeting of an inner nuclear membrane protein in interphase and mitosis
15. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb
16. Identification of an RB-responsive region in the 5′ untranslated region of the RB gene
17. The role of the retinoblastoma gene in breast cancer development
18. Abundance and state of phosphorylation of the retinoblastoma susceptibility gene product in human colon cancer
19. Regulation of retinoblastoma gene expression in hormone-dependent breast cancer
20. Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuroendocrine lung carcinomas
21. Cyclin E, a redundant cyclin in breast cancer
22. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC
23. Regulation of cell proliferation by the E2F transcription factors
24. The retinoblastoma protein: A master regulator of cell cycle, differentiation and apoptosis
25. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells
26. Steroid receptor analyses of nine human breast cancer cell lines
27. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements
28. Requirement of cyclin E-cdk2 inhibition in p16INK4a-mediated growth suppression
29. Phosporylation of retinoblastoma susceptibility gene protein assayed in individual lymphocytes during their mitogenic stimulation
30. Amplification of the CDK4 gene in sarcomas: Tumor specificity and relationship with the RB gene mutation
31. Interactions of 4′6-diamidino-2-phenylindole with synthetic polynucleotides
32. Redundant cyclin overexpression and gene amplification in breast cancer cells
33. A novel cytoplasmic substrate for cdk4 and cdk6 in normal and malignant epithelial derived cells
34. Human retinoblastoma susceptibility gene: Cloning, identification, and sequence
35. Inactivation of the retinoblastoma susceptibility gene in human breast cancers
36. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes
37. Increased RB1 abnormalities in human primary prostate cancer following combined androgen blockade
38. The retinoblastoma gene product is a cell cycle-dependent, nuclear matrix-associated protein
39. Frequent alterations of cell cycle regulators in early-stage breast lesions as detected by immunohistochemistry
40. Control of pRB phosphorylation
41. Modulation of retinoblastoma protein activity during the cell cycle
42. G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment
43. Nuclear import of cdk/cyclin complexes: Identification of distinct mechanisms for import of cdk2/cyclin E and cdc2/cyclin BI
44. Expression of the cyclin-dependent kinase inhibitors p16INK4, p15INK4B and p21WAF1/CIP 1 in human breast cancer
45. High molecular weight protein phosphatase type 1 dephosphorylates the retinoblastoma protein
46. Characterization of the mitotic phase pRb-directed protein phosphatase activity
47. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene
48. Complex formation between lamin A and the retinoblastoma gene product: Identification of the domain on lamin A required for its interaction
49. Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival
50. Cyclins and cyclin-dependent kinases - A biochemical view
51. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution
52. Overview of the biologic markers of breast cancer
53. Association of protein phosphatase-1 delta with the retinoblastoma protein and reversible phosphatase activation in mitotic HeLa cells and in cells released from mitosis
54. Phosphorylation of protein phosphatase-1 isoforms by cdc2 cyclin B in vitro
55. Protein phosphatase-1 alpha, gamma-1, and delta - Changes in phosphorylation and activity in mitotic HeLa cells released from mitotic block
56. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumor suppressor p16INK4a
57. Nuclear association of cyclin D1 in human fibroblasts: Tight binding to nuclear structures and modulation by protein kinase inhibitors
58. Transcriptional activation of functional endogenous estrogen receptor gene expression in MCF10AT cells - A model for early breast cancer
59. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10
60. A human cell line from a pleural effusion derived from a breast carcinoma
61. Extensive DNA methylation spanning the RD promoter in retinoblastoma tumors
62. Immunohistochemical markers of prognostic value in surgical pathology
63. Structural rearrangements of the retinoblastoma gene in human breast carcinoma
64. The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumors
65. Mutational analysis of CDKN2 (MTS1/p16 ink4) in human breast cancer
66. Concentration of RB protein in nucleus vs. cytoplasm is stable as phosphorylation of RB changes during the cell cycle and differentiation
67. Expression of CDK inhibitor genes in immortalized and carcinoma derived breast cell lines
68. Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit